Bacteriophage Therapy of Chronic Nonhealing Wound: Clinical Study
A chronic wound usually results due to halt in the inflammatory phase of wound healing. Bacterial infections and biofilm formation are considered to be the basic cause of it. Chronic wounds significantly impair the quality of life. Antibiotics are now failing due to biofilm formation emergence of dr...
Saved in:
Published in | International journal of lower extremity wounds Vol. 18; no. 2; p. 171 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.06.2019
|
Subjects | |
Online Access | Get more information |
ISSN | 1552-6941 |
DOI | 10.1177/1534734619835115 |
Cover
Loading…
Abstract | A chronic wound usually results due to halt in the inflammatory phase of wound healing. Bacterial infections and biofilm formation are considered to be the basic cause of it. Chronic wounds significantly impair the quality of life. Antibiotics are now failing due to biofilm formation emergence of drug-resistant bacteria.
This study aims to see the effect of bacteriophage therapy in chronic nonhealing wound infected with the following bacteria:
.
Patients with chronic nonhealing wound not responding to conventional local debridement and antibiotic therapy were included in the study. The age of patients ranged between 12 and 60 years.
A total of 20 patients selected and tissue biopsies and wound swabs were taken for isolation of the bacteria. After confirmation of organism, a cocktail of customized bacteriophages was topically applied over the wound on alternate days till the wound surface became microbiologically sterile. Mean bacterial count and clinical assessment were done and compared at the time of presentation and after 3 and 5 doses of application.
A significant improvement was observed in the wound healing, and there were no signs of infection clinically and microbiologically after 3 to 5 doses of topical bacteriophage therapy. Seven patients achieved complete healing on day21 during follow up while in others healthy margins and healthy granulation tissue were observed.
Topical bacteriophage application may be quite effective therapy for the treatment of chronic nonhealing wounds. |
---|---|
AbstractList | A chronic wound usually results due to halt in the inflammatory phase of wound healing. Bacterial infections and biofilm formation are considered to be the basic cause of it. Chronic wounds significantly impair the quality of life. Antibiotics are now failing due to biofilm formation emergence of drug-resistant bacteria.
This study aims to see the effect of bacteriophage therapy in chronic nonhealing wound infected with the following bacteria:
.
Patients with chronic nonhealing wound not responding to conventional local debridement and antibiotic therapy were included in the study. The age of patients ranged between 12 and 60 years.
A total of 20 patients selected and tissue biopsies and wound swabs were taken for isolation of the bacteria. After confirmation of organism, a cocktail of customized bacteriophages was topically applied over the wound on alternate days till the wound surface became microbiologically sterile. Mean bacterial count and clinical assessment were done and compared at the time of presentation and after 3 and 5 doses of application.
A significant improvement was observed in the wound healing, and there were no signs of infection clinically and microbiologically after 3 to 5 doses of topical bacteriophage therapy. Seven patients achieved complete healing on day21 during follow up while in others healthy margins and healthy granulation tissue were observed.
Topical bacteriophage application may be quite effective therapy for the treatment of chronic nonhealing wounds. |
Author | Nath, Gopal Shukla, Vijay K Singh, Hari Shankar Bhartiya, Satyanam Kumar Gupta, Pooja |
Author_xml | – sequence: 1 givenname: Pooja surname: Gupta fullname: Gupta, Pooja organization: 1 Department of Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India – sequence: 2 givenname: Hari Shankar surname: Singh fullname: Singh, Hari Shankar organization: 2 Department of General Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India – sequence: 3 givenname: Vijay K surname: Shukla fullname: Shukla, Vijay K organization: 2 Department of General Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India – sequence: 4 givenname: Gopal surname: Nath fullname: Nath, Gopal organization: 1 Department of Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India – sequence: 5 givenname: Satyanam Kumar surname: Bhartiya fullname: Bhartiya, Satyanam Kumar organization: 2 Department of General Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31081402$$D View this record in MEDLINE/PubMed |
BookMark | eNo1jztPwzAURi0Eog_YmZD_QMDXju2ErUTlIVUwUMRYOfZ1E5TaUR5D_j2RgOnTWT6dsyLnIQYk5AbYHYDW9yBFqkWqIM-EBJBnZAlS8kTlKSzIqu-_GePAcn1JFgJYBinjS7J5NHbAro5tZY5I9xV2pp1o9LSouhhqS99iqNA0dTjSrzgG90CLGWprGvoxjG66IhfeND1e_-2afD5t98VLsnt_fi02u8QKoYfE6JILjc4AeMeVA5OVqiwFm5299l7LWc3mqEBYdLnKM2fQopwx1cx7via3v7_tWJ7QHdquPpluOvy38B9WeEt4 |
CitedBy_id | crossref_primary_10_1111_jam_15647 crossref_primary_10_3390_ijms25105465 crossref_primary_10_3390_antibiotics9110754 crossref_primary_10_3389_fphar_2021_615445 crossref_primary_10_3390_molecules28166098 crossref_primary_10_1155_2024_6252415 crossref_primary_10_3390_antibiotics12020286 crossref_primary_10_3390_ph13100299 crossref_primary_10_1128_MMBR_00012_19 crossref_primary_10_3390_antibiotics9070377 crossref_primary_10_1016_j_ijpharm_2024_124348 crossref_primary_10_3390_ph14111157 crossref_primary_10_3390_ijms23094577 crossref_primary_10_1177_1534734619863116 crossref_primary_10_3389_fbioe_2024_1319830 crossref_primary_10_1371_journal_pone_0243947 crossref_primary_10_1016_j_tim_2021_04_008 crossref_primary_10_3390_antibiotics13020125 crossref_primary_10_3390_biomedicines11102860 crossref_primary_10_1099_jmm_0_001895 crossref_primary_10_1097_TP_0000000000003565 crossref_primary_10_1177_19386400231225708 crossref_primary_10_1016_j_cmi_2023_01_011 crossref_primary_10_3390_ph14010034 crossref_primary_10_1016_j_jgar_2024_07_019 crossref_primary_10_3390_toxins13070491 crossref_primary_10_1002_adma_202201210 crossref_primary_10_1177_15347346211072779 crossref_primary_10_3390_ph16121638 crossref_primary_10_1007_s40121_022_00591_2 crossref_primary_10_3390_antibiotics12040751 crossref_primary_10_3390_pharmaceutics16030374 crossref_primary_10_1007_s15010_024_02178_0 crossref_primary_10_3390_biology13020109 crossref_primary_10_1016_j_indcrop_2025_120608 crossref_primary_10_1080_23744235_2024_2379492 crossref_primary_10_1186_s40634_023_00586_z crossref_primary_10_1016_j_virol_2023_06_009 crossref_primary_10_1111_jam_15642 crossref_primary_10_3390_antibiotics10121497 crossref_primary_10_3389_fmed_2023_1209782 crossref_primary_10_3390_ph14040331 crossref_primary_10_1007_s00253_021_11695_z crossref_primary_10_32604_biocell_2023_029564 crossref_primary_10_1177_15347346231226342 crossref_primary_10_1002_phar_2806 crossref_primary_10_1161_JAHA_121_023080 crossref_primary_10_1055_s_0040_1715773 crossref_primary_10_3390_v16030478 crossref_primary_10_5005_jp_journals_10068_3053 crossref_primary_10_1016_S1473_3099_21_00612_5 crossref_primary_10_22141_2224_0586_20_5_2024_1740 crossref_primary_10_1007_s11908_020_00742_x crossref_primary_10_1186_s40001_023_01121_7 crossref_primary_10_7759_cureus_71542 crossref_primary_10_3390_microbiolres13010002 crossref_primary_10_3390_v16081275 crossref_primary_10_3390_ph18010081 crossref_primary_10_1080_14787210_2021_1858800 crossref_primary_10_3390_antibiotics12081329 crossref_primary_10_1093_burnst_tkae083 crossref_primary_10_1007_s12223_021_00946_1 crossref_primary_10_36610_j_jsaas_2022_090200097x crossref_primary_10_1038_s41598_021_98457_z crossref_primary_10_2174_0118742858281566231221045303 crossref_primary_10_3390_antibiotics8040182 crossref_primary_10_1111_wrr_13240 crossref_primary_10_1111_1751_7915_13465 crossref_primary_10_3390_ijms25010201 crossref_primary_10_1016_j_jconrel_2023_10_029 crossref_primary_10_3390_antibiotics10050556 crossref_primary_10_3390_v15071427 crossref_primary_10_1038_s41598_025_92032_6 crossref_primary_10_1128_spectrum_03702_22 crossref_primary_10_36290_der_2023_028 crossref_primary_10_1016_j_actpha_2022_07_042 crossref_primary_10_3390_v12020235 crossref_primary_10_3390_v13061175 crossref_primary_10_1016_j_mtbio_2023_100612 crossref_primary_10_1080_08927014_2021_1955866 crossref_primary_10_1007_s00203_024_04168_0 crossref_primary_10_1186_s12893_022_01521_2 crossref_primary_10_3390_v14122760 crossref_primary_10_1016_j_apsb_2022_05_007 crossref_primary_10_3390_v16071051 crossref_primary_10_36610_j_jsaas_2022_090200097 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1177/1534734619835115 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
EISSN | 1552-6941 |
ExternalDocumentID | 31081402 |
Genre | Journal Article Observational Study |
GroupedDBID | --- -TM .2E .2J .2N 01A 0R~ 123 1~K 29J 31R 31U 31X 31Z 4.4 53G 54M 5VS AABMB AACMV AACTG AADTT AADUE AAEWN AAGMC AAJPV AAKGS AAQDB AAQXI AARDL AARIX AATAA AATBZ AAUAS AAWTL ABAWP ABCCA ABCJG ABEIX ABFWQ ABHQH ABJNI ABKRH ABLUO ABPNF ABQXT ABRHV ABUJY ABVFX ABXGC ACARO ACDSZ ACDXX ACFEJ ACGFS ACGZU ACJER ACJTF ACLFY ACLZU ACOFE ACOXC ACROE ACRPL ACSBE ACSIQ ACTQU ACUAV ACUIR ACXKE ACXMB ADBBV ADNMO ADNON ADRRZ ADVBO ADYCS ADZZY AECGH AEDTQ AEFTW AEKYL AENEX AEPTA AEQLS AERKM AESZF AEUHG AEUIJ AEWDL AEWHI AEXNY AFEET AFKRG AFMOU AFQAA AFUIA AFWMB AGHKR AGKLV AGNHF AGPXR AGWFA AGWNL AHDMH AHHFK AIIQI AIOMO AJUZI AJXAJ ALKWR ALMA_UNASSIGNED_HOLDINGS ALTZF AMCVQ ANDLU ARTOV ASPBG AUTPY AUVAJ AVWKF AYAKG AZFZN B3H B8M B8R B8Z B94 BBRGL BDDNI BKIIM BKSCU BPACV BSEHC BWJAD C45 CAG CDWPY CFDXU CGR COF CS3 CUY CVF DB0 DC- DC. DF0 DO- DOPDO DV7 DV9 EBS ECM EIF EJD EMOBN F5P FEDTE FHBDP GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION H13 HF~ HVGLF HZ~ IAO IEA IHR INH INR IVC J8X K.F M4V N9A NPM O9- OVD P.B P2P Q7L Q7U Q83 RIG ROL S01 SAUOL SCNPE SDB SFC SFK SFT SGO SGR SGV SGZ SHG SNB SPJ SPP SPQ SPV STM TEORI ZONMY ZPPRI ZRKOI ZSSAH |
ID | FETCH-LOGICAL-c337t-a7b237eda11fd26d1a8b6bb30734f7ff75097c9e613ced9698daece513c470ff2 |
IngestDate | Wed Feb 19 02:26:42 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | microbial infection antibiotic resistance topical bacteriophage therapy chronic wound |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c337t-a7b237eda11fd26d1a8b6bb30734f7ff75097c9e613ced9698daece513c470ff2 |
PMID | 31081402 |
ParticipantIDs | pubmed_primary_31081402 |
PublicationCentury | 2000 |
PublicationDate | 2019-Jun |
PublicationDateYYYYMMDD | 2019-06-01 |
PublicationDate_xml | – month: 06 year: 2019 text: 2019-Jun |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | International journal of lower extremity wounds |
PublicationTitleAlternate | Int J Low Extrem Wounds |
PublicationYear | 2019 |
SSID | ssj0021097 |
Score | 2.4528167 |
Snippet | A chronic wound usually results due to halt in the inflammatory phase of wound healing. Bacterial infections and biofilm formation are considered to be the... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 171 |
SubjectTerms | Administration, Topical Adolescent Adult Bacteriophages Child Chronic Disease Escherichia coli - virology Female Humans Male Middle Aged Normal Distribution Phage Therapy - methods Prognosis Prospective Studies Pseudomonas aeruginosa - virology Staphylococcus aureus - virology Statistics, Nonparametric Wound Healing - physiology Wound Infection - microbiology Wound Infection - therapy Young Adult |
Title | Bacteriophage Therapy of Chronic Nonhealing Wound: Clinical Study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31081402 |
Volume | 18 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dj9JAEN-AJpd7MRrPOz01--DbpUjbbZf6hkQhJhIT4OSN7Gc4PlpiIBd98k93ptsPRC56vjSlSwvdmZ38ZnbmN4S8kcgZZZXvaeMnHjOJ9qQWzAtjI1WgZCwl1jt_HsaDCfs0jaaNxs-9rKXdVrbUj6N1Jf8jVbgGcsUq2XtItnooXIBzkC8cQcJw_CcZv3dUy9lmjpk3Y0cQ4BIsXGebYZYiEsRwwFfsn4T-f6-shRxVzLKLOp29jg7ucUqssJXaFZjxb2aNqP0Wn1WB8f5u4yDolyxbVFZ-BD-ah2wG4I0jL3S6FFUi8Gi-W67ye65vFuJ7HWsdChfn6YMvv9qPSGARVJk51TKFFY0CDytkj5vZytt1NtN3PVj-tOX5bjJYZMZDBn5eB_c8o_2vwqRt1rlsAaQidVfw99EDdu1yqEma4Gdg41SM9hQOO-7O11vbbw__yik5KW8_cEpycDJ-TB4VXgXtOhV5QhomfUq6v6kHLdSDZpYW6kFr9aC5eryjpXLQXDnOyOTjh3Fv4BUdMzwVhnzrCS6DkBstfN_qINa-6OBqQzvOLLcW4SFXiQEMp4xO4qSjhVEmgo-Mt60NnpEHaZaaC0JFKDRAQSsVZyxisH7bynCMpkgu26F5Ts7dG882jhZlVs7FiztHLslprS8vyUML69C8AlC3la_zmf8FFnRNIw |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bacteriophage+Therapy+of+Chronic+Nonhealing+Wound%3A+Clinical+Study&rft.jtitle=International+journal+of+lower+extremity+wounds&rft.au=Gupta%2C+Pooja&rft.au=Singh%2C+Hari+Shankar&rft.au=Shukla%2C+Vijay+K&rft.au=Nath%2C+Gopal&rft.date=2019-06-01&rft.eissn=1552-6941&rft.volume=18&rft.issue=2&rft.spage=171&rft_id=info:doi/10.1177%2F1534734619835115&rft_id=info%3Apmid%2F31081402&rft_id=info%3Apmid%2F31081402&rft.externalDocID=31081402 |